Asthmapolis has just closed a $5 Million Series A round of funding from The Social+Capital Partnership. Asthmapolis makes an FDA approved â€œsmartâ€ asthma inhaler that helps patients and health providers better monitor, visualize, and understand the behavior of asthma by utilizing a sensor that attaches to an inhaler.
Asthmapolis, on the other hand, is on a mission to hack your inhaler.
Asthmapolis will use the funding to build new sensors that work with other inhaled medications, accelerate plans to secure regulatory clearances in countries outside of the US, and also help market their products. For more information, check out articles on TechCrunch and MobiHealthNews.